Intrinsic Value

The intrinsic value of Integral Diagnostics Ltd (IDX) under the Base Case is 2.19 AUD per share. Compared with the current market price of 2.1 AUD, the stock appears Undervalued by 4% .

The intrinsic value is calculated using the DCF method. The model assumes net margin rises from 2.8% last year to 7.9% by 2031, above its five-year average of 0%. Revenue grows about 6% a year over the next five years, less than half its five-year pace of 18%.

Do our valuations actually work? See backtest results .

IDX Intrinsic Value
AU$2.19
Undervaluation 4%
Intrinsic Value
Price AU$2.1

IDX is valued in line with its history. A discount of this size has been typical over the past 5 years.

Monitor IDX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value AU$1.75
Get notified when the price drops into your buy zone
Intrinsic Value AU$2.19
Current Price AU$2.1
Margin of Safety 20% AU$1.75
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to IDX

Fundamental Analysis

What Integral Diagnostics Does

Health Care

Integral Diagnostics is a diagnostic imaging provider. It runs clinics that perform scans and other tests such as X-rays, CT, MRI, ultrasound, and related radiology services. Its business sits in the middle of the healthcare system: doctors and hospitals send patients to its sites when they need images to diagnose injury or disease.

Headquarters
Australia AU
Employees
3 025
IPO date
Oct 21, 2015
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Integral Diagnostics Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one IDX stock?

The intrinsic value for Integral Diagnostics Ltd (IDX) under the Base Case is 2.19 AUD.

Is IDX stock undervalued or overvalued?

Compared with the current market price of 2.1 AUD, the stock appears Undervalued by 4% .

Back to Top